LATOYA VICTOR: Open Payments
NPI 1538559778 · SILVER SPRING, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,032 in 47 payments from 14 companies in 2025. Trend: 2023 $28 · 2024 $355 · 2025 $1,032
Food & beverage: $1,032
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $174 |
| Lundbeck LLC | 6 | $148 |
| Otsuka America Pharmaceutical, Inc. | 6 | $145 |
| Vanda Pharmaceuticals Inc. | 4 | $96 |
| Alkermes, Inc. | 4 | $92 |
| Indivior Inc. | 2 | $81 |
| E.R. Squibb & Sons, L.L.C. | 3 | $71 |
| Tris Pharma Inc | 2 | $43 |
| Collegium Pharmaceutical, Inc. | 2 | $41 |
| Axsome Therapeutics, Inc. | 2 | $38 |
Products named: REXULTI, VRAYLAR, HETLIOZ, SUBLOCADE, COBENFY, LYBALVI, Dyanavel XR, Jornay PM.
Industry payments across MD — which companies pay providers there.
